OraSure Technologies, Inc. (OSUR) Bulls Bet On a Move to Double-Digits

OraSure Technologies, Inc. tagged a fresh 52-week peak right out of the gate today

Oct 16, 2014 at 9:54 AM
facebook twitter linkedin


Ebola has been dominating headlines of late, and diagnostic specialist OraSure Technologies, Inc. (NASDAQ:OSUR) is one name that's been capitalizing on the growing fear, tacking on roughly 26% month-to-date. It's no surprise then, to see call players active on the stock, and yesterday, volume soared to 211 times the average daily pace. Short-term contracts were particularly popular, as evidenced by OSUR's 30-day at-the-money implied volatility (IV), which surged 94.1% to 128.9% -- a 52-week peak.

Drilling down, a number of speculators bet on -- or hedged against -- a move to double-digit territory over the next five weeks. Specifically, buy-to-open activity was detected at OSUR's October and November 10 calls. Delta on the front-month call -- which expires at tomorrow night's close -- is docked at 0.39, and 0.51 for the back-month call, which will expire at the close on Friday, Nov. 21.

On the charts, OraSure Technologies, Inc. (NASDAQ:OSUR) has not traded north of $10 in two years. As noted, though, the equity -- along with a number of biopharmaceutical firms -- has been in rally mode of late. In fact, the stock jumped 12% right of the gate today, and to a new annual high of $9.58, after Canaccord Genuity raised its price target on OSUR by $1 to $12, and underscored its "buy" rating, on speculation the company is developing a test for the virus. At last check, OSUR was up 9.5% to linger near $9.11.

 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

Schaeffer's Investment Research Master Portfolio Trial
 


 


 
Special Offers from Schaeffer's Trading Partners